Aktuelles - Seite 2 von 1 - Seite 2 von 2

Newsletters

09 November 2017 Phase I Studie

Das hTTP-Register nahm an der Phase I Studie teil, bei welcher rekombinanter humaner ADAMTS-13 als therapeutische Möglichkeit bei der Behandlung der angeborenen TTP untersucht wurde

02 Oktober 2017 Neue Mitarbeiterin - Oktober 2017

Das hTTP Register heisst eine neue Mitarbeiterin willkommen

26 September 2017 First tentative data cut for analysis on the September 26th 2014

The TTP-Registry will have a data cut on the 26.09.14 for a thorough analysis of the collected information so far.

01 März 2017 Shire receives FDA Fast Track designation for recombinant ADAMTS13 (SHP655) for treatment of hereditary thrombotic thrombocytopenic purpura

01 Juli 2016 Corinne Eschler is leaving the TTP Registry

Corinne Eschler finished her MD and is about to start her clinical training.

22 Mai 2015 Data cut for first manuscript was performed on May 22nd 2015

Thank you all for the efforts on data cleaning during the days and weeks before this date.

01 Februar 2015 Magnus Mansouri says Goodbye in February 2015

After three years at the central site of the hereditary TTP registry in Bern, Magnus moves on to start his clinical training.

24 August 2014 Steering Committee Meeting 25 August 2014

The second Steering Committee Meeting was held in Bern, Switzerland.

01 Juni 2014 Recombinant ADAMTS13 - study continues (early summer 2014)

Baxter has announced to continue the awaited Phase I/II trial on recombinant ADAMTS13 by the end of the year 2014.